This study aimed to analyse the characteristics and treatment outcomes of adult patients with
acute lymphoblastic leukaemia (ALL) and construct nomogram predictive models for …

Adult acute lymphoblastic leukemia (ALL) is heterogeneous both biologically and clinically.
The outcomes of ALL have been improved with the application of children-like regimens and …

The cure rate of acute lymphoblastic leukemia (ALL) in adolescents and adults remains
poor. This study aimed to establish a prognostic model for≥ 14-year-old patients with ALL to …

Background: Acute lymphoblastic leukemia (ALL) is associated with inferior overall survival
(OS) and progression-free survival (PFS) in adults due to biologic factors and lower …

An updated strategy combining pediatric-based chemotherapy with risk-oriented allogeneic
hematopoietic cell transplantation (HCT) was evaluated in Philadelphia chromosome …

Background: Advances in treatment and supportive care have significantly improved the
overall survival (OS) of pediatric patients with acute lymphoblastic leukemia (ALL). However …

Background: T-cell acute lymphoblastic leukaemia (T-ALL) is a malignant blood disease
derived from early T-cell progenitor cells. Although intensive chemotherapy has significantly …

Objective Despite that the survival rate in childhood acute lymphoblastic leukemia (cALL) is
excellent, subsets of high-risk patients with cALL still have high relapse rates, and the cure …

Risk stratification is crucial to the successful treatment of acute lymphoblastic leukemia
(ALL). Although numerous risk factors have been identified, an optimal prognostic model for …

Background Acute lymphoblastic leukemia (ALL) is a hematological cancer that causes an
accumulation of immature cells in the bone marrow. The count of white blood cells (WBCs) is …